Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation

Int J Pharm. 2021 Apr 15:599:120438. doi: 10.1016/j.ijpharm.2021.120438. Epub 2021 Mar 2.

Abstract

Cancer has reached pandemic dimensions in the whole world. Although current medicine offers multiple treatment options against cancer, novel therapeutic strategies are needed due to the low specificity of chemotherapeutic drugs, undesired side effects and the presence of different incurable types of cancer. Among these new strategies, nanomedicine arises as an encouraging approach towards personalized medicine with high potential for present and future cancer patients. Therefore, nanomedicine aims to develop novel tools with wide potential in cancer treatment, imaging or even theranostic purposes. Even though numerous preclinical studies have been published with successful preliminary results, promising nanosystems have to face multiple obstacles before adoption in clinical practice as safe options for patients with cancer. In this MiniReview, we provide a short overview on the latest advances in current nanomedicine approaches, challenges and promising strategies towards more accurate cancer treatment.

Keywords: Cancer; Chemotherapy; Drug delivery; Nanodrugs; Nanomedicine.

Publication types

  • Review

MeSH terms

  • Drug Delivery Systems
  • Humans
  • Nanomedicine*
  • Neoplasms* / drug therapy
  • Precision Medicine
  • Theranostic Nanomedicine